GlaxoSmithKline Competitors
| GSK Stock | USD 39.27 0.33 0.83% |
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of GlaxoSmithKline PLC competition on your existing holdings.
GlaxoSmithKline |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of GlaxoSmithKline PLC's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
GlaxoSmithKline PLC Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between GlaxoSmithKline PLC and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of GlaxoSmithKline and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of GlaxoSmithKline PLC ADR does not affect the price movement of the other competitor.
| 0.42 | 0.51 | 0.67 | -0.18 | 0.4 | ALKS | ||
| 0.42 | -0.22 | 0.25 | -0.11 | 0.54 | IRWD | ||
| 0.51 | -0.22 | 0.71 | -0.32 | -0.24 | DCPH | ||
| 0.67 | 0.25 | 0.71 | -0.17 | -0.06 | EGRX | ||
| -0.18 | -0.11 | -0.32 | -0.17 | 0.16 | NBIX | ||
| 0.4 | 0.54 | -0.24 | -0.06 | 0.16 | DVAX | ||
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between GlaxoSmithKline Stock performing well and GlaxoSmithKline PLC Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze GlaxoSmithKline PLC's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| ALKS | 1.75 | (0.32) | 0.00 | (0.11) | 0.00 | 2.79 | 21.89 | |||
| IRWD | 2.51 | (0.50) | 0.00 | (3.86) | 0.00 | 3.82 | 42.91 | |||
| DCPH | 2.22 | (0.11) | (0.02) | 0.00 | 2.52 | 4.84 | 17.94 | |||
| EGRX | 4.14 | 0.13 | 0.03 | 0.16 | 4.87 | 8.00 | 23.10 | |||
| NBIX | 1.17 | (0.01) | (0.04) | 0.00 | 1.56 | 2.61 | 8.06 | |||
| DVAX | 1.14 | (0.37) | 0.00 | (0.52) | 0.00 | 2.49 | 6.78 |
Cross Equities Net Income Analysis
Compare GlaxoSmithKline PLC ADR and related stocks such as Alkermes Plc, Ironwood Pharmaceuticals, and Deciphera Pharmaceuticals Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ALKS | (8.1 M) | (113.7 M) | 25 M | 17.6 M | (30.1 M) | (227.2 M) | (208.4 M) | (157.9 M) | (139.3 M) | (196.6 M) | (110.9 M) | (48.2 M) | (158.3 M) | 355.8 M | 373.5 M |
| IRWD | (52.8 M) | (64.9 M) | (72.6 M) | (272.8 M) | (189.6 M) | (142.7 M) | (81.7 M) | (116.9 M) | (282.4 M) | (15.3 M) | 106.2 M | 528.4 M | 175.1 M | (1 B) | (952.1 M) |
| DCPH | (19.8 M) | (19.8 M) | (19.8 M) | (19.8 M) | (19.8 M) | (19.8 M) | (25.9 M) | (50.3 M) | (99.9 M) | (191.5 M) | (266.5 M) | (296.8 M) | (178.9 M) | (194.9 M) | (204.7 M) |
| EGRX | (19.4 M) | (19.4 M) | (19.4 M) | (6 M) | (18 M) | 2.6 M | 81.5 M | 51.9 M | 31.9 M | 14.3 M | 12 M | (8.6 M) | 35.6 M | 41 M | 43 M |
| NBIX | 5.9 M | 37.6 M | 5 M | (46.1 M) | (60.5 M) | (88.9 M) | (141.1 M) | (142.5 M) | 21.1 M | 37 M | 407.3 M | 89.6 M | 154.5 M | 249.7 M | 262.2 M |
| DVAX | (26.7 M) | (48.6 M) | (69.9 M) | (66.7 M) | (90.7 M) | (106.8 M) | (112.4 M) | (95.2 M) | (158.9 M) | (151.4 M) | (91.8 M) | 76.7 M | 293.2 M | (6.4 M) | (6.7 M) |
GlaxoSmithKline PLC ADR and related stocks such as Alkermes Plc, Ironwood Pharmaceuticals, and Deciphera Pharmaceuticals Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in GlaxoSmithKline PLC ADR financial statement analysis. It represents the amount of money remaining after all of GlaxoSmithKline PLC ADR operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.GlaxoSmithKline PLC Competitive Analysis
The better you understand GlaxoSmithKline PLC competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, GlaxoSmithKline PLC's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across GlaxoSmithKline PLC's competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
GlaxoSmithKline PLC Competition Performance Charts
Five steps to successful analysis of GlaxoSmithKline PLC Competition
GlaxoSmithKline PLC's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by GlaxoSmithKline PLC ADR in relation to its competition. GlaxoSmithKline PLC's competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of GlaxoSmithKline PLC in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact GlaxoSmithKline PLC's competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to GlaxoSmithKline PLC ADR, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your GlaxoSmithKline PLC position
In addition to having GlaxoSmithKline PLC in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run World Allocation Funds Thematic Idea Now
World Allocation Funds
Funds or Etfs investing in stocks, bonds, and cash of domestic markets as well as in markets of Canada, Japan, and Europe. The World Allocation Funds theme has 46 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize World Allocation Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out GlaxoSmithKline PLC Correlation with its peers. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Complementary Tools for GlaxoSmithKline Stock analysis
When running GlaxoSmithKline PLC's price analysis, check to measure GlaxoSmithKline PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GlaxoSmithKline PLC is operating at the current time. Most of GlaxoSmithKline PLC's value examination focuses on studying past and present price action to predict the probability of GlaxoSmithKline PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GlaxoSmithKline PLC's price. Additionally, you may evaluate how the addition of GlaxoSmithKline PLC to your portfolios can decrease your overall portfolio volatility.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Transaction History View history of all your transactions and understand their impact on performance |
Is GlaxoSmithKline PLC's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GlaxoSmithKline PLC. If investors know GlaxoSmithKline will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about GlaxoSmithKline PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.77) | Dividend Share 0.58 | Earnings Share 2.99 | Revenue Per Share 14.97 | Quarterly Revenue Growth 0.092 |
The market value of GlaxoSmithKline PLC ADR is measured differently than its book value, which is the value of GlaxoSmithKline that is recorded on the company's balance sheet. Investors also form their own opinion of GlaxoSmithKline PLC's value that differs from its market value or its book value, called intrinsic value, which is GlaxoSmithKline PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GlaxoSmithKline PLC's market value can be influenced by many factors that don't directly affect GlaxoSmithKline PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GlaxoSmithKline PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if GlaxoSmithKline PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GlaxoSmithKline PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.